FDA Inspection 1089668 — Ohio Reproductive Medicine, Inc.

Ohio Reproductive Medicine, Inc. — FEI 3004563989

The FDA completed an inspection of Ohio Reproductive Medicine, Inc. on May 1, 2019 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbus, OH (United States)